Evommune EVMN Proceeds From Issuance Of Private Placement
Proceeds From Issuance Of Private Placement at other companies
Other financials
Where this comes from
Reported directly by Evommune in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPrivatePlacement.
The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evommune 's proceeds from issuance of private placement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Evommune 's proceeds from issuance of private placement?
- Evommune (EVMN) reported proceeds from issuance of private placement of $8M in Q4 2025.
- What does proceeds from issuance of private placement mean?
- The total cash proceeds received by the company from the sale of securities directly to private investors rather than through a public offering. This metric indicates the company's ability to raise capital outside of public markets and its reliance on private funding sources.